World's Best Scientists 2026 revealed!
Amelia Ruffatti

Amelia Ruffatti

D-Index & Metrics

Biology and Biochemistry

D-Index
51
Citations
9035
World Ranking
17204
National Ranking
545

Overview

Amelia Ruffatti is affiliated with the University of Padua in Italy and has contributed extensively to the field of Medicine, with a particular focus on Rheumatology, Hematology, Genetics, Immunology, and Surgery. Their research primarily explores systemic autoimmune disorders, blood-related diseases, and immune mechanisms.

The topics addressed in Ruffatti's work include:

  • Systemic Lupus Erythematosus Research
  • Blood disorders and treatments
  • Platelet Disorders and Treatments
  • Blood Coagulation and Thrombosis Mechanisms
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Immunodeficiency and Autoimmune Disorders
  • Complement system in diseases

Ruffatti has published research in various medical journals, with frequent appearances in:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • Seminars in Arthritis and Rheumatism
  • Autoimmunity Reviews
  • Blood

Notable recent papers include:

  • The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus (2020, Autoimmunity Reviews)
  • The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies (2020, Seminars in Arthritis and Rheumatism)
  • Markers of complement activation in plasma during quiescent phases in patients with catastrophic antiphospholipid syndrome (2021, Blood)
  • The first thrombotic event in purely obstetric antiphospholipid syndrome patients and in antiphospholipid antibody carriers: comparison of incidence and characteristics (2020, Archives of Gynecology and Obstetrics)
  • High plasma C5a and C5b-9 levels during quiescent phases are associated to severe antiphospholipid syndrome subsets (2021, Clinical and Experimental Rheumatology)

Ruffatti frequently collaborates with a number of coauthors in their research endeavors. Some of the most recurrent collaborators are:

  • Marta Tonello
  • Ariela Hoxha
  • Maria Favarò
  • Teresa Del Ross
  • Antonia Calligaro

The scientist's research interests intersect multiple subfields, reflecting a multidisciplinary approach to understanding complex autoimmune and hematological diseases. Their work often examines the mechanisms of blood coagulation, platelet function, and immune system abnormalities, particularly in conditions such as antiphospholipid syndrome and related disorders.

Best Publications

  • Clinical course of high-risk patients diagnosed with antiphospholipid syndrome

    Vittorio Pengo;Amelia Ruffatti;C Legnani;P Gresele

  • Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study.

    Vittorio Pengo;Amelia Ruffatti;Cristina Legnani;Sophie Testa

  • The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study.

    B. De Laat;V. Pengo;I. Pabinger;J. Musial

  • Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study

    Amelia Ruffatti;Teresa Del Ross;Manuela Ciprian;Maria T Bertero

  • Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.

    Gabriele Saccone;Vincenzo Berghella;Giuseppe Maria Maruotti;Tullio Ghi

  • Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis

    Laurent Arnaud;Laurent Arnaud;Alexis Mathian;Amelia Ruffatti;Doruk Erkan

  • Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity

    Amelia Ruffatti;Marta Tonello;Teresa Del Ross;Anna Cavazzana

  • The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study.

    Arsène Mekinian;Maria Grazia Lazzaroni;Anna Kuzenko;Jaume Alijotas-Reig

  • Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies

    Vittorio Pengo;A Biasiolo;T Brocco;S Tonetto

  • The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases

    Jaume Alijotas-Reig;Raquel Ferrer-Oliveras;Amelia Ruffatti;Angela Tincani

  • International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management

    Roberto Giacomelli;Antonella Afeltra;Alessia Alunno;Chiara Baldini

  • Pregnancy, cytokines, and disease activity in systemic lupus erythematosus

    Andrea Doria;Anna Ghirardello;Luca Iaccarino;Sandra Zampieri

  • Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies.

    Laurent Arnaud;Laurent Arnaud;Alexis Mathian;Hervé Devilliers;Amelia Ruffatti

  • Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification.

    A. Ruffatti;S. Olivieri;M. Tonello;M. Bortolati

  • Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome

    Entela Nuri;Mara Taraborelli;Laura Andreoli;Marta Tonello

  • Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile.

    Vittorio Pengo;Amelia Ruffatti;T. Del Ross;Marta Tonello

  • Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year longitudinal study.

    N Bizzaro;Anna Ghirardello;S Zampieri;Luca Iaccarino

  • Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies.

    T. Marchetti;A. Ruffatti;C. Wuillemin;P. de Moerloose

  • Antibodies to Domain I of β2Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)

    A. Banzato;N. Pozzi;R. Frasson;V. De Filippis

  • Autoantibodies of Systemic Rheumatic Diseases in the Healthy Elderly

    Amelia Ruffatti;Laura Rossi;Antonia Calligaro;Teresa Del Ross

Frequent Co-Authors

Vittorio Pengo
Vittorio Pengo University of Padua
Leonardo Punzi
Leonardo Punzi University of Padua
Angela Tincani
Angela Tincani University of Brescia
Pier Luigi Meroni
Pier Luigi Meroni Istituto Auxologico Italiano
Andrea Doria
Andrea Doria University of Padua
Anna Ghirardello
Anna Ghirardello University of Padua
Ricard Cervera
Ricard Cervera University of Barcelona
Patrizia Rovere-Querini
Patrizia Rovere-Querini Vita-Salute San Raffaele University
Nathalie Costedoat-Chalumeau
Nathalie Costedoat-Chalumeau Université Paris Cité
Paolo Gresele
Paolo Gresele University of Perugia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Graduates in Biology and Biochemistry are finding new opportunities through online education pathways. For those interested in the health field, a popular choice is medical coding. Many prospective students ask, how long does it take to become a medical coder? The answer depends on your commitment, but certificate programs can often be completed in less than a year.

Another career path worth considering is medical billing and coding. Wondering is medical billing and coding worth it? The field offers stability and flexible work options, especially for those who prefer remote or part-time roles.

For students seeking broader roles in healthcare, many are exploring health information management schools online. These degrees can lead to administrative or technology-focused positions in health services.

Nutrition is also a growing field. There are several programs for those seeking advancement, and you can save money by considering the cheapest online master's in nutrition. These programs open doors to roles in wellness coaching, food science, and public health.

Best Scientists Citing Amelia Ruffatti

Trending Scientists

Recently Published Articles